Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KFERQ-selective protein autophagy in Caenorhabditis elegans depends on LMP-1. | PLoS One | 2025 | 40892950 | PubTator, text mining | PubMed |
Whole genome transcriptional analysis of intestinal biopsies and blood cells indicate genes involved in antioxidant defense systems, amino acid metabolism and antigen presentation in the pathogenesis of celiac disease. | BMC Med | 2025 | 40883722 | PubTator, text mining | PubMed |
| The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells. | Elife | 2025 | 40878909 | PubTator, text mining | PubMed |
| Neuronal immunoproteasome and PFKFB3-forced glycolysis: key players in multiple sclerosis. | Signal Transduct Target Ther | 2025 | 40877259 | PubTator, text mining | PubMed |
| A direct RNA-seq-based EBV latency transcriptome offers insights into the biogenesis of EBV gene products. | J Gen Virol | 2025 | 40857085 | PubTator, text mining | PubMed |
| Current landscape of the immunoproteasome: implications for disease and therapy. | Cell Death Discov | 2025 | 40855068 | PubTator, text mining | PubMed |
| [iPSC-derived next-generation T cell therapy for refractory malignancies]. | Rinsho Ketsueki | 2025 | 40769931 | PubTator, text mining | PubMed |
| Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia. | Blood Neoplasia | 2025 | 40746940 | PubTator, text mining | PubMed |
| Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data. | J Immunother Cancer | 2025 | 40744664 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Genetic Landscape of Non-Remitting Neutropenia in Children and Chronic Idiopathic Neutropenia in Adults. | Int J Mol Sci | 2025 | 40725177 | PubTator, text mining | PubMed |
| The growing interests in Epstein-Barr virus: A bibliometric analysis of research trends, collaborations, and emerging hotspots. | Infect Med (Beijing) | 2025 | 40703323 | PubTator, text mining | PubMed |
| Correction to "Proteasome Subunit LMP2 Is Required for Matrix Metalloproteinase-2 and -9 Expression and Activities in Human Invasive Extravillous Trophoblast Cell Line". | J Cell Physiol | 2025 | 40685967 | PubTator, text mining | PubMed |
| Extending the Projection-Based Embedding Technique to Open-Shell Systems Using the Huzinaga Equation. | J Chem Theory Comput | 2025 | 40674599 | PubTator, text mining | PubMed |
| Complexome profiling showed impaired immunoproteasome assembly in a novel PRAAS subtype caused by monoallelic PSMB8 variants. | medRxiv | 2025 | 40666351 | PubTator, text mining | PubMed |
| Epstein-Barr virus (EBV) infection of endothelial cells via endocytosis is associated with a poor prognosis in nasopharyngeal carcinoma. | Microbiol Spectr | 2025 | 40631744 | PubTator, text mining | PubMed |
| Identification of potential pathogenic genes associated with the comorbidity of rheumatoid arthritis and renal fibrosis using bioinformatics and machine learning. | Sci Rep | 2025 | 40596265 | PubTator, text mining | PubMed |
| Improving cutaneous melanoma prognosis through adjusting PSMB9 expression: A diagnostic accuracy study based on the construction and optimization of an artificial neural network model. | Medicine (Baltimore) | 2025 | 40587698 | PubTator, text mining | PubMed |
| Epstein-Barr virus (EBV) reactivation in post COVID-19. | Auris Nasus Larynx | 2025 | 40578132 | PubTator, text mining | PubMed |
| The value of plasma immunoproteasome for predicting coronary collateral circulation in ST-elevation myocardial infarction. | Biomark Med | 2025 | 40536446 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=5